Results 231 to 240 of about 34,741 (308)
Transcriptomic Analysis of the Human Habenula in Schizophrenia. [PDF]
Yalcinbas EA +21 more
europepmc +1 more source
EAGLE SYMBOL IN TURKISH ICONOGRAPHY AND IT'S REFLECTION TO THE CONTEMPORARY TURKISH PAINTING
İbrahim Çoban
openalex +1 more source
Light‐Driven Quadrupedal Walking Biohybrid Robot With Antagonistic Muscle‐Rings and Inclined Joints
This work presents a light‐driven quadrupedal walking biohybrid robot powered by antagonistic muscle‐rings that achieve alternating walking gait. Optical training improved reproducibility of cultured muscle tissues, while caffeine treatment enhanced contractile force.
Shotaro Saito +5 more
wiley +1 more source
Unveiling the Myth: Harpy Eagle <i>Harpia harpyja</i> Attacks on a Human in the Amazon Forest. [PDF]
Epelboin L +10 more
europepmc +1 more source
Our study reveals the protective role of GPR124 in maintaining BBB integrity and promoting neurological recovery following TBI. It makes a significant contribution by uncovering a novel molecular interaction between GPR124 and FGFBP1 and linking this to activation of the Wnt/β‐catenin signaling pathway in vascular repair mechanisms.
Chen Wang +13 more
wiley +1 more source
PD‐1 Inhibits CD4+ TRM‐Mediated cDC1 Mobilization via Suppressing JAML in Human NSCLC
CD4+ tissue‐resident memory T cells (TRMs) in non‐small cell lung cancer recruit conventional type 1 dendritic cells via XCL1‐XCR1 signaling, orchestrating antitumor immunity. The costimulatory molecule JAML is essential for this process. PD‐1 blockade restores JAML expression and cDC1 mobilization, while JAML agonists synergize with anti‐PD‐1 therapy,
Zheyu Shao +16 more
wiley +1 more source
Genome of venomous caterpillar <i>Doratifera vulnerans</i> reveals recruitment of immune peptides and their adaptation as pain-inducing toxins. [PDF]
Goudarzi MH +11 more
europepmc +1 more source
A novel therapy using engineered immune cells (NAC‐T cells) showed promise for refractory malignant mesothelioma. Based on the encouraging preclinical data, the first‐in‐human trial is initiated, demonstrating tolerable safety and promising anti‐tumor activity (ORR 63.6%, DCR 100%, including one CR).
Yan Sun +23 more
wiley +1 more source

